Pathway Medical
Pathway Medical, founded in 2018 in Montreal, built an AI-powered medical question-answering platform that synthesized clinical guidelines and literature for clinicians, serving hundreds of thousands of users before its 2025 acquisition by Doximity for $63 million.
- Company typePrivate
- Founded2018
- HeadquartersMontreal, Canada
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Pathway Medical does
Pathway Medical was a Montreal-based health technology company founded in 2018 that built an AI-powered medical question-answering platform for clinicians. The platform synthesized peer-reviewed medical literature, clinical guidelines, drug databases, and clinical trial data into point-of-care answers, and was reported to achieve 96% accuracy on the USMLE benchmark. Pathway served hundreds of thousands of registered clinicians globally through a self-serve, freemium distribution model, with no disclosed enterprise contracts or paid tiers.
The company's underlying technology combined knowledge retrieval, natural language processing, and generative AI capabilities, trained on a proprietary AI-ready dataset covering medical guidelines, drugs, and clinical trials. Core founders included Jonathan Hershon Saint-Jean (CEO), Christophe Marois (CTO), and Louis Mullie (CMO). Pathway raised seed funding totaling approximately C$5 million plus US$5 million in November 2023, led by Yamaha Motor Ventures with Verge HealthTech Fund participation, following an earlier ~$1.29 million round in 2021.
In July 2025, Pathway was acquired by Doximity for $63 million ($26 million in cash plus up to $37 million in equity grants). The company's capabilities were integrated into Doximity Ask, a free AI-powered clinical reference tool distributed to Doximity's physician user base. The business model under Pathway's independent operation was freemium, with monetization, if any, flowing indirectly through Doximity post-acquisition.
Pathway Medical firmographics
Firmographics- Name
- Pathway Medical
- Legal name
- Pathway Medical Inc.
- Website
- https://pathway.md
- Company type
- Private
- Founded year
- 2018
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- Pathway Medical, founded in 2018 in Montreal, built an AI-powered medical question-answering platform that synthesized clinical guidelines and literature for clinicians, serving hundreds of thousands of users before its 2025 acquisition by Doximity for $63 million.
- Ownership category
- akta.pro rank
Pathway Medical industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG)
Keywords
Where Pathway Medical is headquartered
LocationHeadquarters
- HQ city
- Montreal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Pathway Medical business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure
Revenue model
- Clinical Reference Tool (via Doximity): Pathway Medical was acquired by Doximity in 2025. The technology now lives on in Doximity Ask, a free AI-powered clinical reference tool for clinicians. Revenue generation through this tool likely occurs via Doximity's broader platform monetization.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free AI-powered clinical reference tool |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Pathway Medical product offering
Product offeringCore offering
Pathway Medical developed an AI-powered clinical question-answering platform that synthesizes peer-reviewed medical literature, clinical guidelines, drug information, and clinical trials to answer physicians' clinical questions at the point of care. The platform served hundreds of thousands of registered clinician users and achieved 96% accuracy on the USMLE benchmark, and following the 2025 acquisition by Doximity, its capabilities now live on within Doximity Ask.
Product overview
Pathway Medical was a Montreal-based health technology company that developed AI-powered clinical decision support tools. The company offered a unified medical question-answering platform that provided clinicians and patients with access to synthesized medical literature, clinical guidelines, drug information, and trials. Pathway achieved 96% accuracy on the USMLE benchmark. In 2025, Pathway Medical was acquired by Doximity for $63 million, and its capabilities were integrated into Doximity Ask, a free AI-powered clinical reference tool now serving the Doximity platform's clinician user base.
Differentiator
Problem solved
Functional benefit
Products and services
- Pathway (Original AI Clinical Reference Platform) AI-powered medical question-answering platform that gave clinicians and patients access to synthesized peer-reviewed medical literature, clinical guidelines, drug information, and clinical trials, providing evidence-based answers to clinical questions at the point of care.
- Doximity Ask (incorporating Pathway capabilities) Free AI-powered clinical reference tool providing clinicians with synthesized medical literature and guidelines directly within the tools they already use at the point of care, distributed through Doximity's physician platform.
Quantifiable outcome
- 96% accuracy on USMLE benchmark
- +1 more outcomes
Companies that use Pathway Medical
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Pathway Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature3 records
Pathway Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DoximitycoreDoximity acquired Pathway Medical in July 2025 for $63 million ($26M cash + up to $37M equity grants). Pathway's AI-powered clinical reference technology was integrated into Doximity Ask, enhancing Doximity's clinical reference capabilities.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
Pathway Medical competitors and assessment
Company assessmentDirect peers
- Nabla: Nabla provides an AI clinical assistant that generates clinical notes and supports point-of-care decision making for physicians, comparable in target user (clinicians), AI modality, and workflow integration to Pathway.
- Glass Health: Glass Health builds an AI clinical decision support platform that helps clinicians with differential diagnosis, treatment plans, and point-of-care reference, directly comparable to Pathway's medical question-answering capabilities.
- Suki AI: Suki AI offers an AI assistant for clinicians that automates documentation and surfaces clinical information, comparable to Pathway as a clinician-facing AI tool integrated into physician workflows.
- OpenEvidence: OpenEvidence provides an AI-powered medical question-answering platform for clinicians, directly competing with Pathway's core offering of synthesized medical literature and guideline-based answers at the point of care. The two companies have also clashed legally, with OpenEvidence suing Pathway over alleged trade secret theft.
Broad incumbents
- Veradigm (formerly Allscripts): Veradigm is an established healthcare IT vendor offering EHR and clinical decision support solutions to hospitals and physician practices. It competes broadly with Pathway by embedding evidence-based reference and CDS within clinical workflows at scale.
- Doximity: Doximity is the largest professional network for U.S. physicians and the acquirer of Pathway. It offers news, paperwork, referrals, telehealth, and now AI-powered clinical reference (Doximity Ask), overlapping with Pathway's point-of-care decision support capabilities.
- Wolters Kluwer UpToDate: UpToDate is the established evidence-based clinical decision support resource used by clinicians worldwide. It competes with Pathway's mission to help physicians quickly access synthesized medical literature and guidelines, but relies on human-authored content rather than generative AI.
- Anthropic (Claude for Healthcare): Anthropic's Claude is a frontier general-purpose LLM increasingly used by clinicians for medical reasoning and clinical reference, representing a broad incumbent threat to specialized clinical AI tools like Pathway.
Emerging players
- Hippocratic AI: Hippocratic AI builds safety-focused large language models for healthcare, with clinical reasoning capabilities tested against medical benchmarks including USMLE-style questions. Comparable to Pathway in building domain-specific medical AI for clinical use.
- Atropos Health: Atropos Health provides AI-augmented real-world evidence and clinical decision support for physicians, leveraging proprietary data to answer clinical questions. It overlaps with Pathway in providing evidence-based answers to clinicians at the point of care.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Pathway Medical social profiles
Digital presencePathway Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pathway Medical leadership team
Management profileNumber of profiles
Profiles3 records
Pathway Medical funding detail
Funding detailFunding overview
Funding rounds3 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pathway Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pathway Medical
What does Pathway Medical do?
Pathway Medical developed an AI-powered clinical question-answering platform that synthesizes peer-reviewed medical literature, clinical guidelines, drug information, and clinical trials to answer physicians' clinical questions at the point of care. The platform served hundreds of thousands of registered clinician users and achieved 96% accuracy on the USMLE benchmark, and following the 2025 acquisition by Doximity, its capabilities now live on within Doximity Ask.
Is Pathway Medical a public or private company?
Pathway Medical is a private company. It is classified as venture growth investor backed and is currently acquired.
When was Pathway Medical founded?
Pathway Medical was founded in 2018. It employs 1 to 10 people.
Where is Pathway Medical based?
Pathway Medical is headquartered in Montreal, Canada, in the North America region.
How does Pathway Medical make money?
One revenue line is on record: clinical Reference Tool (via Doximity).
Who are Pathway Medical's main competitors?
Direct peers on record are Nabla, Glass Health, Suki AI and OpenEvidence. Broad incumbents are Veradigm (formerly Allscripts), Doximity, Wolters Kluwer UpToDate and Anthropic (Claude for Healthcare). Emerging players are Hippocratic AI and Atropos Health.
Does Pathway Medical have an API?
No public API is recorded for Pathway Medical.
What industry is Pathway Medical in?
Pathway Medical's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAG, Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD). Its NAICS code is 54151 and its SIC code is 7372.